CCL vs TERN · P/E 15, rev $25.02B vs $6.12B cap
Carnival Corporation (CCL) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CCL and TERN stock pages for the full models.
Not investment advice.